EconPapers    
Economics at your fingertips  
 

Pharmacoepidemiology

Edeltraut Garbe and Samy Suissa
Additional contact information
Edeltraut Garbe: Charité-University Medicine Berlin, Institute for Clinical Pharmacology
Samy Suissa: McGill University, Departments of Epidemiology and Biostatistics

Chapter III.9 in Handbook of Epidemiology, 2005, pp 1225-1266 from Springer

Abstract: Abstract In the last two decades we have witnessed a tremendous progress in the medical sciences that has led to the development of a great number of new powerful pharmaceuticals. These new medicines enable us to provide much better medical care, but occasionally they will cause harm and give rise to serious adverse reactions that were unexpected from preclinical studies or premarketing clinical trials. Against this background, pharmacoepidemiology has developed as a scientific discipline at the interface between clinical pharmacology and clinical epidemiology (cf. Chap. III.8 of this handbook). Pharmacoepidemiology can be defined as the application of epidemiologic knowledge, methods, and reasoning to the study of the effects and uses of drugs in human populations (Porta-Serra and Hartzema 1997). The application of epidemiological methods – i.e. the use of nonexperimental observational techniques –, the epidemiological perspective with an emphasis on investigations in large unselected populations and long-term studies, the public health approach and the philosophy of epidemiology are all extended to the scope of clinical pharmacology, i.e. the study of the effects of pharmaceuticals in humans.

Keywords: Chronic Obstructive Pulmonary Disease; Propensity Score; Drug Utilization; General Practice Research Database; Cohort Entry (search for similar items in EconPapers)
Date: 2005
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-540-26577-1_31

Ordering information: This item can be ordered from
http://www.springer.com/9783540265771

DOI: 10.1007/978-3-540-26577-1_31

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2026-06-25
Handle: RePEc:spr:sprchp:978-3-540-26577-1_31